In the 6-OHDA-induced PD rat model, it was found that decreased tau levels did not improve the neurotoxic damage of 6-OHDA in the animal model of PD, which may not alert abnormal aggregation of α-synuclein and production of LBs, lacking interaction with homogenous α-synuclein [41]. Here, MAPT is linked to Parkinson disease.